Logo image of WEED.CA

CANOPY GROWTH CORP (WEED.CA) Stock Fundamental Analysis

TSX:WEED - Toronto Stock Exchange - CA1380357048 - Common Stock - Currency: CAD

2.04  -0.07 (-3.32%)

Fundamental Rating

2

Taking everything into account, WEED scores 2 out of 10 in our fundamental rating. WEED was compared to 35 industry peers in the Pharmaceuticals industry. While WEED seems to be doing ok healthwise, there are quite some concerns on its profitability. WEED does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year WEED has reported negative net income.
WEED had a negative operating cash flow in the past year.
In the past 5 years WEED always reported negative net income.
WEED had a negative operating cash flow in each of the past 5 years.
WEED.CA Yearly Net Income VS EBIT VS OCF VS FCFWEED.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -1B -2B -3B

1.2 Ratios

Looking at the Return On Assets, with a value of -65.18%, WEED is doing worse than 85.71% of the companies in the same industry.
WEED's Return On Equity of -122.76% is on the low side compared to the rest of the industry. WEED is outperformed by 77.14% of its industry peers.
Industry RankSector Rank
ROA -65.18%
ROE -122.76%
ROIC N/A
ROA(3y)-83.37%
ROA(5y)-56.25%
ROE(3y)-219.63%
ROE(5y)-143.17%
ROIC(3y)N/A
ROIC(5y)N/A
WEED.CA Yearly ROA, ROE, ROICWEED.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -100 -200 -300 -400

1.3 Margins

WEED has a Gross Margin of 30.30%. This is comparable to the rest of the industry: WEED outperforms 48.57% of its industry peers.
The Profit Margin and Operating Margin are not available for WEED so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 30.3%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
WEED.CA Yearly Profit, Operating, Gross MarginsWEED.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200 -400 -600 -800

More info and screens

4

2. Health

2.1 Basic Checks

WEED does not have a ROIC to compare to the WACC, probably because it is not profitable.
WEED has more shares outstanding than it did 1 year ago.
WEED has less shares outstanding than it did 5 years ago.
The debt/assets ratio for WEED has been reduced compared to a year ago.
WEED.CA Yearly Shares OutstandingWEED.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M
WEED.CA Yearly Total Debt VS Total AssetsWEED.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

Based on the Altman-Z score of -12.61, we must say that WEED is in the distress zone and has some risk of bankruptcy.
WEED's Altman-Z score of -12.61 is on the low side compared to the rest of the industry. WEED is outperformed by 85.71% of its industry peers.
A Debt/Equity ratio of 0.64 indicates that WEED is somewhat dependend on debt financing.
WEED's Debt to Equity ratio of 0.64 is on the low side compared to the rest of the industry. WEED is outperformed by 60.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF N/A
Altman-Z -12.61
ROIC/WACCN/A
WACC11.42%
WEED.CA Yearly LT Debt VS Equity VS FCFWEED.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B

2.3 Liquidity

A Current Ratio of 3.12 indicates that WEED has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 3.12, WEED is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
WEED has a Quick Ratio of 2.10. This indicates that WEED is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 2.10, WEED belongs to the best of the industry, outperforming 82.86% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.12
Quick Ratio 2.1
WEED.CA Yearly Current Assets VS Current LiabilitesWEED.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 36.55% over the past year.
WEED shows a decrease in Revenue. In the last year, the revenue decreased by -9.49%.
Measured over the past years, WEED shows a decrease in Revenue. The Revenue has been decreasing by -7.57% on average per year.
EPS 1Y (TTM)36.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-26.08%
Revenue 1Y (TTM)-9.49%
Revenue growth 3Y-19.22%
Revenue growth 5Y-7.57%
Sales Q2Q%-24.74%

3.2 Future

The Earnings Per Share is expected to grow by 15.30% on average over the next years. This is quite good.
Based on estimates for the next years, WEED will show a small growth in Revenue. The Revenue will grow by 4.65% on average per year.
EPS Next Y89.17%
EPS Next 2Y38.4%
EPS Next 3Y23.33%
EPS Next 5Y15.3%
Revenue Next Year7.13%
Revenue Next 2Y6.99%
Revenue Next 3Y5.98%
Revenue Next 5Y4.65%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
WEED.CA Yearly Revenue VS EstimatesWEED.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 100M 200M 300M 400M 500M
WEED.CA Yearly EPS VS EstimatesWEED.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 -20 -40 -60

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

WEED reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for WEED. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
WEED.CA Price Earnings VS Forward Price EarningsWEED.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
WEED.CA Per share dataWEED.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 -4

4.3 Compensation for Growth

A more expensive valuation may be justified as WEED's earnings are expected to grow with 23.33% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.4%
EPS Next 3Y23.33%

More info and screens

0

5. Dividend

5.1 Amount

WEED does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CANOPY GROWTH CORP

TSX:WEED (6/13/2025, 7:00:00 PM)

2.04

-0.07 (-3.32%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)05-30 2025-05-30/bmo
Earnings (Next)08-07 2025-08-07/bmo
Inst Owners8.19%
Inst Owner ChangeN/A
Ins Owners0.94%
Ins Owner ChangeN/A
Market Cap428.67M
Analysts46.67
Price Target3.62 (77.45%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-136.02%
Min EPS beat(2)-170.88%
Max EPS beat(2)-101.15%
EPS beat(4)0
Avg EPS beat(4)-185.86%
Min EPS beat(4)-240.27%
Max EPS beat(4)-101.15%
EPS beat(8)1
Avg EPS beat(8)-176.05%
EPS beat(12)1
Avg EPS beat(12)-194.61%
EPS beat(16)4
Avg EPS beat(16)-136.89%
Revenue beat(2)1
Avg Revenue beat(2)-3.78%
Min Revenue beat(2)-13.61%
Max Revenue beat(2)6.06%
Revenue beat(4)1
Avg Revenue beat(4)-3.99%
Min Revenue beat(4)-13.61%
Max Revenue beat(4)6.06%
Revenue beat(8)4
Avg Revenue beat(8)2.12%
Revenue beat(12)5
Avg Revenue beat(12)-1.29%
Revenue beat(16)6
Avg Revenue beat(16)-3.44%
PT rev (1m)0%
PT rev (3m)-7.39%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)4.19%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)6.11%
Revenue NY rev (1m)0%
Revenue NY rev (3m)4.51%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.59
P/FCF N/A
P/OCF N/A
P/B 0.88
P/tB 1.21
EV/EBITDA N/A
EPS(TTM)-5.49
EYN/A
EPS(NY)-0.59
Fwd EYN/A
FCF(TTM)-0.84
FCFYN/A
OCF(TTM)-0.79
OCFYN/A
SpS1.28
BVpS2.32
TBVpS1.68
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -65.18%
ROE -122.76%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 30.3%
FCFM N/A
ROA(3y)-83.37%
ROA(5y)-56.25%
ROE(3y)-219.63%
ROE(5y)-143.17%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 26.16%
Cap/Sales 4.19%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.12
Quick Ratio 2.1
Altman-Z -12.61
F-Score5
WACC11.42%
ROIC/WACCN/A
Cap/Depr(3y)15.39%
Cap/Depr(5y)45.04%
Cap/Sales(3y)2.72%
Cap/Sales(5y)9.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)36.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-26.08%
EPS Next Y89.17%
EPS Next 2Y38.4%
EPS Next 3Y23.33%
EPS Next 5Y15.3%
Revenue 1Y (TTM)-9.49%
Revenue growth 3Y-19.22%
Revenue growth 5Y-7.57%
Sales Q2Q%-24.74%
Revenue Next Year7.13%
Revenue Next 2Y6.99%
Revenue Next 3Y5.98%
Revenue Next 5Y4.65%
EBIT growth 1Y48.52%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year103.26%
EBIT Next 3Y30.78%
EBIT Next 5Y20.32%
FCF growth 1Y38.09%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y41.21%
OCF growth 3YN/A
OCF growth 5YN/A